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Abstract
Background: Health professionals are expected to engage pregnant women in shared decision making to help
them make informed values-based decisions about prenatal screening. Patient decision aids (PtDAs) foster shared
decision-making, but are rarely used in this context. Our objective was to identify factors that could influence
health professionals to use a PtDA for decisions about prenatal screening for Down syndrome during a clinical
pregnancy follow-up.
Methods: We planned to recruit a purposive sample of 45 health professionals (obstetrician-gynecologists, family
physicians and midwives) involved in the care of pregnant women in three clinical sites (15 per site). Participating
health professionals first watched a video showing two simulated consecutive prenatal follow-up consultations
during which a pregnant woman, her partner and a health professional used a PtDA about Down syndrome
prenatal screening. Participants were then interviewed about factors that would influence their use of the PtDA.
Questions were based on the Theoretical Domains Framework. We performed content analyses of transcribed
verbatim interviews.
Results: Out of 42 eligible health professionals approached, 36 agreed to be interviewed (86 % response rate). Of
these, 27 were female (75 %), nine were obstetrician-gynecologists (25 %), 15 were family physicians (42 %), and 12
were midwives (33 %), with a mean age of 42.1 ± 11.6 years old. We identified 35 distinct factors reported by 20 % or
more participants that were mapped onto 10 of the 12 of the Theoretical Domains Framework domains. The six most
frequently mentioned factors influencing use of the PtDA were: 1) a positive appraisal (n = 29, 81 %, beliefs about
consequences domain); 2) its availability in the office (n = 27, 75 %, environmental context and resources domain); 3)
colleagues’ approval (n = 27, 75 %, social influences domain); 4) time constraints (n = 26, 72 %, environmental context
and resources domain); 5) finding it a relevant source of information (n = 24, 67 %, motivation and goals domain); and
6) not knowing any PtDAs (n = 23, 64 %, knowledge domain).
Conclusions: Appraisal, PtDA availability, peer approval, time concerns, evidence and PtDA awareness all affect
whether health professionals are likely to use a PtDA to help pregnant women make informed decision about Down
syndrome screening. Implementation strategies will need to address these factors.
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Background
The decision about whether or not to take the prenatal test
for Down syndrome (DS) is a difficult one [1, 2]. Future
parents have to decide in a context of uncertainty where
results cannot be predicted or guaranteed [3–5]. The deci-
sion requires an understanding of probability data, such as
the personal risk of carrying a fetus with DS, and of screen-
ing test characteristics such as detection, false-positive and
false-negative rates. This sensitive decision can also lead to
a further, more sensitive decision (i.e. terminating the
pregnancy or preparing for a child with special needs).
Moreover, with the increased availability of Non-Invasive
Prenatal Testing (NIPT) for women considering DS
screening, future parents will need to be well supported in
the decision process to work through the strengths and
limitations of all the available tests, including the option
not to test [6–8].
Health professionals are expected to engage pregnant
women in shared decision-making to help them make
informed values-based decisions [9–12]. Shared
decision-making is an interpersonal and interdependent
process in which providers and patients collaborate in
making decisions about the patient’s health care. The
evidence, the providers’ clinical expertise and the
unique attributes of patients and their families all play
a part in this decision [13, 14]. Using a patient decision
aid (PtDA) is one effective way to foster shared
decision-making in clinical practice [15, 16]. A system-
atic review of 115 trials of PtDAs has demonstrated
their efficacy: they increase patients’ knowledge scores,
their risk perception, the match between their values
and choices, and they help patients who are undecided
to make up their minds [17]. Despite their proven
effectiveness, the widespread adoption of PtDAs has
not yet been achieved [18, 19]. In addition, few PtDAs
for the decision about DS screening have been identi-
fied, and none of them met all the 16 minimum criteria
established by the International Patient Decision Aids
Standards (IPDAS) [20, 21]. To address possible rea-
sons for low PtDA uptake among various health profes-
sionals and to provide information for strategies to
implement PtDAs for the decision about DS prenatal
screening, we sought to identify factors influencing
health professionals’ use of a PtDA about prenatal
screening for DS during a clinical pregnancy follow-up.
This qualitative study will serve as a first step to devel-
oping a theory-based survey questionnaire to quantita-
tively identify the determinants of health professionals’
intention to use a PtDA for DS screening decisions in
preparation for an implementation intervention to pro-
mote its optimal use in routine clinical practice.
Methods
Study design and context
This qualitative study was embedded in a sequential explora-
tory mixed-methods study aiming to implement the use of a
PtDA to foster shared decision-making in the context of pre-
natal screening for DS. The overall study is part of the
PEGASUS project (PErsonalized Genomics for prenatal An-
euploidy Screening USing maternal blood, Canada). Ethics
approval was obtained from the research ethics boards of the
Centre de Santé et de Services Sociaux de la Vieille-Capitale
(#2013-2014-29) and the CHU de Québec (#B14-02-1929).
Participants and recruitment
Prenatal care in the province of Quebec, Canada, is offered
by obstetrician-gynecologists (about 51 % of pregnancies),
family physicians (about 46 %) or midwives (about 3 %)
[22]. We wanted to maximize the diversity of perspectives
by drawing from clinical sites representing different team
approaches to prenatal care and different clienteles.
According to Godin et al., for this kind of qualitative study,
a minimal sample of 25 to 30 participants is recommended
to identify all relevant opinions [23]. We thus aimed to re-
cruit a convenience sample of 45 participants with 15 par-
ticipants in each professional category. We recruited health
professionals from three health centers in the Quebec City
area, Canada: obstetrician-gynecologists in a university
hospital, family physicians in a family practice teaching unit
and midwives in a birthing center.
We included health professionals who were: a) in-
volved in prenatal care; b) family physicians, midwives,
obstetrician-gynecologists or interns in these profes-
sions; and c) working in any of the three health centers
targeted. We excluded health professionals who were
on parental or sick leave.
The project coordinator and a research assistant first
met the family physicians, the midwives and the
obstetrician-gynecologists during a regular professional
meeting to explain the study process and secure their
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collaboration. A research assistant was then assigned to
each site to generate a list of health professionals likely to
be eligible based on their affiliations, functions and em-
ployment status. The research assistant then approached
these health professionals, explained the project briefly, as-
sured them that data would be anonymous and confiden-
tial, confirmed their eligibility, and invited them to
participate. Each participant then signed a consent form
and agreed to an interview appointment over the following
ten business days.
Data collection
Participants were interviewed either at their health cen-
ter or on the phone, depending on their preferences and
availability. Before the interview, participants watched a
10-min video showing two simulated consecutive pre-
natal follow-up consultations between a health profes-
sional and a pregnant women and her partner. During
the first visit, the health professional gives a PtDA to the
couple, explains its purpose, reviews its content and ex-
plains the risks and benefits of doing or not doing the
prenatal testing. At this point the video presents a close-
up of the content of the PtDA page by page and item by
item. However, the interviewed health professionals were
not offered a printed copy of the decision aid to look at.
The PtDA presented in the video had been developed
earlier by the team based on an existing decision support
tool [24]. Then the health professional invites the couple
to look over the PtDA at home. The health professional
clarifies that the pregnant women is facing the decision
to undergo prenatal screening for DS and that more in-
formation can be found in the PtDA that will help the
decision-making process. In the second visit (4 weeks
later), the pregnant woman, still accompanied by her
partner, discusses the decision with the health profes-
sional and says she has made her choice. However, the
viewer does not find out what she has chosen so that
participants would not be influenced by her choice. Im-
mediately after watching the video, to identify factors in-
fluencing the use of a PtDA for DS screening during a
clinical pregnancy follow-up, semi-structured interviews
took place consisting of 11 open-ended questions based
on the Theoretical Domains Framework: 1) knowledge/
awareness, 2) advantages, 3) disadvantages, 4) incentives,
5) emotions, 6) anticipated regret, 7) social approval, 8)
social disapproval, 9) appraisal/evaluation, 10) facilitators
and 11) barriers [25].
The Theoretical Domains Framework is comprised of
12 theoretical domains relevant to behavioral change
[25–27]. It postulates that factors influencing behavior
change can be mapped onto these theoretical domains
and can be used to design effective theory-based imple-
mentation interventions. In this study, the behavior of
interest was defined as follows: use (action) of a PtDA
about prenatal screening test for DS (target) in the con-
text of a prenatal care follow-up with a health profes-
sional (context) [28]. Time was not specified, as the
behavior was hypothetical. At the end of the interview,
we also assessed participants’ socio-demographic charac-
teristics. Interviews were audio-recorded and transcribed
verbatim. Each recording had an identification code and
was uploaded to our database.
Data analysis
To identify participants’ salient beliefs (henceforth re-
ferred to as “opinions”), the second author (MELP) ana-
lyzed the full transcripts using a content analysis
approach. Then, using N-Vivo v.10 software (QSR Inter-
national, Melbourne, Australia), similar opinions were
grouped into themes (henceforth referred to as “influen-
tial factors”) which were mapped onto the Theoretical
Domains Framework constructs and then onto 10 of its
12 domains: 1) beliefs about consequences, 2) environ-
mental context and resources, 3) social influences, 4) so-
cial/professional role and identity, 5) knowledge, 6)
emotions, 7) beliefs about capabilities, 8) motivation and
goals, 9) skills, and 10) behavioral regulation. No influ-
ential factors mapped onto the two remaining theoretical
domains, which are 11) memory, attention and decision
processes, and 12) nature of the behaviors. These do-
mains were less relevant to our participants, probably
because they had hardly ever used PtDAs in the clinic
before [25]. The first author (JL) independently read all
the transcripts and double-checked the tree-node. She
suggested the addition of relevant categories or themes
and the removal of less relevant ones, and discussed a
final coding scheme with the second author. Any dis-
crepancies were resolved through discussion with team
members. The same procedure was undertaken with all
identified influential factors. The number of participants
who identified the same influential factor, along with the
percentage rate, was calculated for each health profes-
sional category (n, %, Table 2) and for all professional
categories together (N, %, Table 2). Modal beliefs were
also identified (superscripted "a" in Table 2), i.e. the most
frequently reported influential factors for each construct
(up to 75 %), to give a sense of the relative importance
of this factor (some factors, for example, were men-
tioned more than once by a single participant) [23]. The
frequencies of modal beliefs were calculated by summing
the total number of quotes for each influential factor (Q)
as well as the percentage of times that the same opinion
was repeated per construct (%QC) (Table 2).
Results
Participant characteristics
Out of 73 eligible health professionals, 42 were approached
between July 25, 2014 and February 28, 2015, and 36
Lépine et al. BMC Pregnancy and Childbirth  (2016) 16:262 Page 3 of 10
agreed to complete interviews (86 % overall participation
rate), including 15 family physicians (79 %), 12 midwives
(92 %) and nine obstetrician-gynecologists (90 %). The
remaining 31 eligible family physicians were not
approached because we stopped recruitment once we had
reached the expected sample size for this category (n = 15,
Fig. 1). Twenty-seven women (75 %) and nine men (25 %)
were recruited; four participants were interns (11 %,
Table 1); and two obstetrician-gynecologists were inter-
viewed by phone (6 %) instead of in person (n = 34, 94 %,
data not shown). The mean age was 42.1 ± 11.6 years old,
mean practice experience was 12.6 ± 12.0 years, and mean
number of prenatal visits per week was 17.4 ± 21.5. The
mean length of interviews including video viewing
(10 min) was 28 ± 6 min (Table 1).
Influential factors
A total of 64 influential factors (see Additional file 1)
were reported by participating health professionals re-
garding the use of a PtDA for deciding about prenatal
screening for DS during a pregnancy follow-up visit, in-
cluding 35 factors that were reported by 20 % or more
participants in any health professional category
(Table 2).
Beliefs about consequences domain
This domain has four theoretical constructs: advantages,
disadvantages, anticipated regret and appraisal. The two
most frequently reported advantages of using a PtDA for
decisions about prenatal screening for DS were: 1) it helps
patients to think about the decision [N = 18(50 %); Q =
25(44 %)a]; and 2) its visual content is helpful for patients
[N = 11(31 %); Q = 14(25 %)a]. Obstetrician-gynecologists
reported these two advantages less frequently (n = 3, 33 %
and n = 2, 22 %, respectively) than did the other two pro-
fessionals. Five midwives (n = 5, 42 %) said that an advan-
tage of the PtDA was that it enables patients to express
their preferences, while only one obstetrician-gynecologist
(n = 1, 11 %) and two family-physicians (n = 2, 13 %)
reported this. Four midwives (n = 4, 33 %) and three
obstetrician-gynecologists (n = 3, 33 %) thought that
another advantage was that PtDAs promote decision
making, but only one family physician thought this (n = 1,
7 %, Table 2).
The most frequently reported disadvantage was that
PtDA use did not fit in with the timing of the current DS
prenatal screening program covered by the government of
the province of Quebec [N = 13(36 %); Q = 15(45 %)a].
While the video proposes 4 weeks for thinking about the
decision between the first prenatal visit and the second,
pregnant women may actually have less than 3 weeks
between the first visit, generally between 10 and 12 weeks
of pregnancy, and the first blood sample for DS screening,
which must be between 10 and 13 weeks of pregnancy.
While only one family physician mentioned this (n = 1,
7 %), five midwives (n = 5, 42 %) and seven obstetrician-
gynecologists (n = 7, 78 %) mentioned this factor. The latter
also said more frequently that the PtDA content is incom-
plete (n = 4, 44 %, Table 2).
Overall, for the anticipated regret construct, more
health professionals said they would regret it if they
did not use a PtDA [N = 16(44 %); Q = 16(62 %)a] com-
pared to those who said they would not regret it [N =
10(28 %); Q = 10(38 %)a]. Almost all midwives men-
tioned they would regret not using it (n = 8, 67 %),
while family physicians (n = 5, 33 %) and obstetrician-
gynecologists (n = 3, 33 %) were less likely to regret
not using it (Table 2).
For the appraisal construct, the majority of health profes-
sionals appraised the use of a PtDA positively, i.e. thought
its use would be good, useful, beneficial, or excellent [N =
29(81 %); Q = 33(92 %)a], especially midwives (n = 12,
100 %) (Table 2).
Environmental context and resources domain
This domain has two constructs: facilitators and barriers.
The most frequently reported facilitator was its availabil-
ity in the office [N = 27(75 %); Q = 47(67 %)a]. Midwives
mentioned comprehensibility for patients more fre-
quently than the others (n = 5, 42 %) and a quarter men-
tioned having enough time to present it as a facilitator
(n = 3, 25 %, Table 2).
Fig. 1 Flow of the participants. FP family physicians, MW midwives;
and OG obstetrician-gynecologists
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The two most frequently reported barriers were: 1)
not having enough time to present it during a clinical
encounter [N = 26(72 %); Q = 48(58 %)a]; and 2) if it is
too complex for patients [N = 16(44 %); Q = 21(25 %)a].
Some family physicians considered PtDAs in print form
only as a barrier (n = 3, 20 %) while some midwives con-
sidered unbalanced/biased PtDAs as a barrier (n = 3,
25 %, Table 2).
Social influences domain
This domain has two opposite constructs: people who
would approve and people who would disapprove.
Health professionals most frequently reported their col-
leagues as being both the people who would approve of
their using a PtDA [N = 27(75 %); Q = 29(64 %)a], and to
a lesser extent, the people who would disapprove of it [N =
11(31 %); Q = 11(58 %)a]. No obstetrician-gynecologists re-
ported their family as a social influence (Table 2), and only
a few health professionals said that their patients/clients
would approve [N = 5(14 %); Q = 5(11 %), see Additional
file 1] or disapprove of PtDA use [N = 2(6 %); Q = 2(11 %),
see Additional file 1].
Social/professional role and identity domain
This domain has one construct: moral norms. The most
frequently reported factor relating to moral norms was
that seven health professionals felt it was their duty to
present the PtDA to their patients [N = 7(19 %); Q =
8(67 %)a] (Table 2).
Knowledge domain
The majority of health professionals said they did not
know of any PtDAs [N = 23(64 %); Q = 23(59 %)a]
although some said they knew about the government
pamphlet (not a decision aid [21]) on the prenatal
screening program covered by the province of Quebec
[N = 10(28 %); Q = 10(26 %)a] [29]. Some participants
reported that they knew of PtDAs for other decisions
(prostate cancer, breast cancer, and respiratory tract
infections) [N = 6(17 %); Q = 6(15 %)]. More midwives
than other health professionals were aware of the exist-
ence of PtDAs (only four said they did not know of any
PtDAs, n = 4, 33 %) and of the government pamphlet (n
= 9, 75 %) about prenatal screening for DS. Family physi-
cians appeared to be more familiar with PtDAs for other
decisions (n = 4, 27 %, Table 2).
Emotions domain
The most frequently reported emotion regarding the use
of a PtDA was that its use would give satisfaction [N =
8(22 %); Q = 9(53 %)a], especially among obstetrician-
gynecologists (n = 4, 44 %, Table 2).
Beliefs about capabilities domain
This domain has one construct: self-efficacy. The most
frequently reported factor about self-efficacy was that
health professionals would feel comfortable using it [N
= 11(31 %); Q = 13(68 %)a], especially midwives (n = 7,
58 %, Table 2).
Motivation and goals domain
This domain has one construct: incentives. The most fre-
quently reported incentive was that health professionals
would use the PtDA because it is a relevant source of in-
formation [N = 24(67 %); Q = 38(75 %)a]. However, fewer
obstetrician-gynecologists thought so (n = 4, 44 %). Com-
pared to the others, fewer family physicians mentioned
the incentive of having to decide with their patients (n = 1,
7 %, Table 2).
Skills domain
Health professionals reported only one influential factor
in the skills development construct. Overall, a quarter of
the health professionals said they would need prior
training to use the PtDA properly during a clinical en-
counter [N = 9(25 %); Q = 11(100 %)a], while fewer
obstetrician-gynecologists thought so (n = 1, 11 %,
Table 2).









Age (years)a 40.5 ± 13.4 39.8 ± 8.0 48.1 ± 11.7 42.1 ± 11.6
Sex (n women/men) 10/5 12/0 5/4 27/9
Experience (years)a 13.0 ± 12.7 7.7 ± 5.5 18.3 ± 15.2 12.6 ± 12.0
Prenatal visits/weeka 5.4 ± 5.4 13.6 ± 4.2 42.6 ± 30.5 17.4 ± 21.5
Internship student (n) 3 0 1 4
Interview lengths (min)ab 26 ± 6 31 ± 6 27 ± 3 28 ± 6
FP family physicians, MW midwives; and OG obstetrician-gynecologists
aMean ± SD
bInterview lengths include watching the video (10 min.)
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Behavioral regulation domain
This domain has one construct: action planning. The
two most frequently reported preliminary steps were
that the PtDA could be explained by a nurse before the
consultation [N = 11(31 %); Q = 17(57 %)a], followed by
that the PtDA could be given to patients before the con-
sultation [N = 7(19 %); Q = 13(43 %)a]. None of the mid-
wives reported these two factors (Table 2).
Table 2 Frequency of most prevalent influential factors reported by each category of health professional and overall















Beliefs about consequences Advantages It helps patients to think about
the decision
1 8 (53) 7 (58) 3 (33) 18 (50) 25 (44)a
Its visual content is helpful for
patients
2 5 (33) 4 (33) 2 (22) 11 (31) 14 (25)a
It enables expression of preferences 3 2 (13) 5 (42) 1 (11) 8 (22) 9 (16)
It promotes decision making 4 1 (7) 4 (33) 3 (33) 8 (22) 9 (16)
Disadvantages Its use didn’t fit in with program
timing
5 1 (7) 5 (42) 7 (78) 13 (36) 15 (45)a
Its content is incomplete 6 2 (13) 2 (17) 4 (44) 8 (22) 10 (30)a
Anticipated regret I would regret if I didn’t use it 7 5 (33) 8 (67) 3 (33) 16 (44) 16 (62)a
I would not regret if I didn’t use it 8 4 (27) 1 (8) 5 (56) 10 (28) 10 (38)a
Appraisal Positive appraisal 9 11 (73) 12 (100) 6 (67) 29 (81) 33 (92)a
Negative appraisal 10 0 (0) 1 (8) 2 (22) 3 (8) 3 (8)
Environmental context
and resources
Facilitators Its availability in the office 11 12 (80) 9 (75) 6 (67) 27 (75) 47 (67)a
Its comprehensibility for patients 12 3 (20) 5 (42) 1 (11) 9 (25) 10 (14)a
It must be brief 13 2 (13) 2 (17) 2 (22) 6 (17) 7 (10)
I have enough time to present it 14 1 (7) 3 (25) 0 (0) 4 (11) 4 (6)
Barriers Not having enough time to present it 15 12 (80) 7 (58) 7 (78) 26 (72) 48 (58)a
If it is too complex for patients 16 5 (33) 7 (58) 4 (44) 16 (44) 21 (25)a
If it is available in print form only 17 3 (20) 0 (0) 0 (0) 3 (8) 4 (5)
If its content is unbalanced/biased 18 0 (0) 3 (25) 0 (0) 3 (8) 3 (4)
Social influences Approve Colleagues 19 11 (73) 11 (92) 5 (56) 27 (75) 29 (64)a
My family 20 3 (20) 3 (25) 0 (0) 6 (17) 7 (16)a
Disapprove Colleagues 21 5 (33) 4 (33) 2 (22) 11 (31) 11 (58)a
A colleague with extensive experience 22 3 (20) 0 (0) 0 (0) 3 (8) 3 (16)a
Social/professional role
and identity
Moral norms It is my duty to present it 23 2 (13) 3 (25) 2 (22) 7 (19) 8 (67)a
Knowledge Knowledge I don’t know of any PtDAs 24 11 (73) 4 (33) 8 (89) 23 (64) 23 (59)a
I know the government pamphlet 25 1 (7) 9 (75) 0 (0) 10 (28) 10 (26)a
I know a PtDA for another decision 26 4 (27) 1 (8) 1 (11) 6 (17) 6 (15)
Emotions Emotions Give me satisfaction 27 2 (13) 2 (17) 4 (44) 8 (22) 9 (53)a
Reassure me 28 3 (20) 1 (8) 0 (0) 4 (11) 4 (24)a
Beliefs about capabilities Self-efficacy I feel comfortable to use it 29 3 (20) 7 (58) 1 (11) 11 (31) 13 (68)a
Motivation and goals Incentives It is a relevant source of information 30 11 (73) 9 (75) 4 (44) 24 (67) 38 (75)a
If I have to decide with my patient 31 1 (7) 6 (50) 3 (33) 10 (28) 11 (22)
My patient’s uncertainty 32 0 (0) 0 (0) 2 (22) 2 (6) 2 (4)
Skills Skills development Need a prior training to use it properly 33 4 (27) 4 (33) 1 (11) 9 (25) 11 (100)a
Behavioral regulation Action planning Its prior presentation by a nurse 34 8 (53) 0 (0) 3 (33) 11 (31) 17 (57)a
Given to patient before consultation 35 2 (13) 0 (0) 5 (56) 7 (19) 13 (43)a
TDF Theoretical Domains Framework, #IF Influential factor number (see Table 3), FP family physicians, MW midwives, OG obstetrician-gynecologists. Q Number of
quotes for each influential factor , %QC Percentage of times that each influential factor was repeated per construct
amodal beliefs
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Table 3 presents examples of opinions (translated from
the French originals) by participants that illustrate each
of the 35 influential factors (IF) listed in Table 2.
Discussion
In this qualitative study, we elicited factors influencing
the use of a PtDA in the context of prenatal screening
for DS by family physicians, midwives and obstetrician-
gynecologists, three categories of health professional
involved in prenatal care. Six influential factors were
reported by a total of 60 % or more participants: 1) a
positive appraisal of PtDA use, 2) its availability in their
offices, 3) their colleagues’ approval of them using it, 4)
not having enough time to present it, 5) it is a relevant
source of information for them and their patients, and
6) not knowing about PtDAs (in decreasing order of fre-
quency). These results lead us to make four
observations.
First, all six of the most-reported influential factors in our
study have previously been reported about the use of other
PtDAs by diverse health professionals (i.e. respirologists,
family physicians, gynecologists, geriatricians, surgeons,
oncologists). A highly positive appraisal of three PtDAs was
reported by Graham et al. in 2007 and to a lesser extent in
2003 [30, 31]. The easy availability of PtDAs as a facilitator
has not been clearly reported elsewhere, but their lack of
availability has been noted as a disadvantage or barrier,
which amounts to the same thing [30, 32]. Graham et al.
also identified colleagues’ approval as an important influen-
tial factor [30, 31]. Surprisingly, very few health profes-
sionals in our study mention their patients as a social
influence (approval or disapproval) on their use of a PtDA,
despite the fact that PtDAs are designed for them. In our
study, the most frequent barrier reported about the use of a
PtDA was the lack of time to present it. This barrier is
widely reported in the literature about PtDAs and especially
about shared decision-making implementation [19, 30–33].
The belief that PtDA is a relevant source of information for
both clinicians and the patients is also supported in other
studies [30, 31]. Finally, a lack of knowledge/awareness of
PtDAs among health professionals, our sixth most influen-
tial factor, is supported by Brace et al. [32]. Any implemen-
tation strategy for use of PtDAs about DS screening in the
clinic needs to specifically consider these six most import-
ant factors, a finding consistent with results of previous
studies.
Second, some influential factors had different frequen-
cies depending on the category of health professional.
Family physicians appeared to be more familiar with
PtDAs for other decisions. More midwives were aware of
the existence of PtDAs and were more likely than the
others to feel that a PtDA could encourage patients to ex-
press their preferences. Midwives also felt they would be
more comfortable using it, and they did not report that
Table 3 Examples of opinions that illustrate each influential
factors
#IF Illustrative opinions (translated from the French originals)
1 It forces the patients to think a little. (OG)
2 A visual aid is certainly a tool that helps people understand things
better. (OG)
3 The fact that they can write what matters most to them, it is a good
process. (MW)
4 We make sure that patient has really given informed consent. (OG)
5 I don’t have time to give it to women and wait for them to come
back, it will be too late. (OG)
6 There’s just information about the public screening, but I also talk
about private tests. (OG)
7 I would feel bad if I didn’t use it. (MW)
8 I wouldn’t feel guilty for not using it. (OG)
9 I would find it good. I think that it is a good tool. (FP)
10 There are people who think that it is not useful. (OG)
11 It would help to have a bunch of copies. (OG)
12 It must be simple and easy to use. (FP)
13 Anyway, it must be short and sweet. (MW)
14 We have one and a half hours for the first visit, so we have time to
present it. (MW)
15 The time we have is a disadvantage. (OG)
16 I would not use it if it is too confusing. (MW)
17 Our patients tell us: You gave me too many documents to read, I
didn’t read it. (FP)
18 If I have the feeling that the tool promotes one choice, I would feel
uncomfortable using it (MW)
19 The other midwives. (MW)
20 I have children, who have children, and I think they would approve of
my using it. (FP)
21 I would say probably the team. (FP)
22 Those who have more experience could dissuade me. (FP)
23 I have no choice but to give it to patients. (FP)
24 Not at all! (FP)
25 I know this pamphlet. (MW)
26 For prostate cancer, with the little cartoons. (FP)
27 It would be satisfaction. (MW)
28 It would reassure me, because I have something that proves what I’m
telling them (FP)
29 I would feel comfortable to use it. (FP)
30 It is interesting to have evidence about the problem. (FP)
31 I would use it to help me to help them to make a decision. (MW)
32 I would give the tool to a couple who is really undecided. (OG)
33 To train us how to transmit it to couples. (MW)
34 One part could be done by the nurse beforehand and I could do the
other part. (OG)
35 Maybe if patients have it in advance, and have done a first reading
before meeting us. (FP)
#IF Influential factor number (see Table 2). FP family physicians, MW midwives;
and OG obstetrician-gynecologists
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prior presentation/handing out of the PtDA could be a
useful preliminary step. The attitude of obstetrician-
gynecologists regarding PtDA use was less positive overall:
they reported advantages and social approval less fre-
quently and disadvantages more frequently, and fewer pre-
dicted they would regret it if they did not use it. Similarly
divergent factors among eight types of healthcare pro-
viders regarding the intention to engage in an shared
decision-making approach in home care have been ob-
served elsewhere [34]. These findings suggest that strat-
egies to implement PtDAs for DS screening need to be
tailored to different types of health professionals.
Third, the most frequent barrier and fourth most fre-
quently reported influential factor overall was not having
enough time to present a PtDA. This is the most widely
reported barrier to implementing shared decision-
making in clinical practice across numerous cultural and
organizational contexts [19]. Although one study sug-
gested that longer consultations were associated with
higher shared decision-making scores on the OPTION
scale [35], there is no consistent evidence to support that
more time is required for shared decision-making than
for conventional care [17]. Interestingly, midwives in our
study appeared to dedicate more time to their clients for
each prenatal visit (an hour and a half for the first visit)
than the other two professionals and they also dedicated
117 % more time to the interviews (Table 1). However,
midwives were slightly less likely to mention time con-
cerns. Future programs implementing PtDA use must
address this perceived time constraint. Rather than add-
ing yet another task to the health professional’s work-
load, a PtDA could help them replace their consultation
style with an shared decision-making approach, espe-
cially if patients have a chance to read the PtDA before
the consultation and could themselves become advocates
for shared decision-making.
Lastly, there is a great need to publicize the existence
and proven benefits of those PtDAs that have been vali-
dated and rigorously assessed. PtDAs about DS screen-
ing, as well as the Quebec government pamphlet [29],
were almost unknown to our participants, especially for
family physicians and obstetricians-gynecologists. A
study in the context of cancer treatment found a similar
proportion of respondents who said the main barrier to
their using PtDAs was lack of awareness of their exist-
ence [32]. This issue could be addressed by opinion
leaders endorsing their use [36]. Governments (such as
Quebec’s) that have developed information about DS
screening could publicize it better [29].
This study has limitations. First, we recruited health pro-
fessionals in the Quebec City area. This could limit
generalization to Canada and to other countries. Secondly,
we did not reach our targeted sample of 15 participants for
midwives (n = 12) and obstetrician-gynecologist (n = 9),
because only 13 midwives and 11 obstetrician-
gynecologists were eligible in their respective recruitment
sites. However, we observed influential factors saturation,
or redundancy, at n = 13/15 for family physicians, n = 8/12
for midwives and n = 7/9 for obstetrician-gynecologists,
and thus consider we collected all the most prevalent fac-
tors. Third, the video shown just prior to the interviews
presented a female family physician meeting a couple in a
family practice teaching unit. Males, obstetrician-
gynecologists and midwives might therefore have felt their
situation and concerns were unrepresented; while family
physicians might have been tempted to compare their
practice with the one depicted in the video. Such feelings
may have influenced health professionals’ identification of
influential factors. However, we made every effort to miti-
gate this potential limitation by making the video as rele-
vant as possible to all categories of health professional. We
also followed a validated processthat has been successfully
used pre viously [37]. The fourth limitation was that our
interview grid had only 11 open ended questions. It is pos-
sible that adding more questions could have identified more
factors [26, 38]. However, we made sure to cover all relevant
domains (10 out of 12) and our formula of open-ended
questions allowed participants to elaborate on their opinions
extensively. We also checked with each participant that they
had shared all their thoughts before ending the interview.
Conclusion
Positive appraisal, easy availability, peer approval, time
concerns, evidence, and PtDA awareness all affect
whether health professionals are likely to use a PtDA to
help pregnant women make decisions about screening
for DS. These factors could inform the design of relevant
PtDAs for DS screening and inform tailored strategies
for implementing them. Our team will use these qualita-
tive results to develop a theory-based survey question-
naire to quantitatively identify the determinants of
health professionals’ intention to use a PtDA for DS
screening decisions in preparation for an implementa-
tion intervention to promote its optimal use in routine
clinical practice. In parallel, our team is leading a study
with the same objectives with pregnant women [39].
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